Online Prescriptions

Online Prescriptions - Click Here
HomeAlpha IndexCategories

Bookmark and Share

Prescriptions : A

Prescriptions : B

Prescriptions : C

Prescriptions : D

Prescriptions : E

Prescriptions : F

Prescriptions : G

Prescriptions : H

Prescriptions : I

Prescriptions : J

Prescriptions : K

Prescriptions : L

Prescriptions : M

Prescriptions : N

Prescriptions : O

Prescriptions : P

Prescriptions : Q

Prescriptions : R

Prescriptions : S

Prescriptions : T

Prescriptions : U

Prescriptions : V

Prescriptions : W

Prescriptions : X

Prescriptions : Y

Prescriptions : Z

Prescriptions : 0-9

Home

Product Index

Category List

Cyclo Progynova Generic Estradiol valerate

Home » Prescription Drugs 5 » Cyclo Progynova Generic Estradiol valerate

Product Origin: EU (Turkey)

This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.

Medical Information

Cyclo-Progynova is a hormone replacement therapy (HRT) preparation. Each pack contains two types of tablets. The white tablets contain estradiol valerate and the pale brown tablets contain estradiol valerate in combination with norgestrel. Estradiol valerate (previously spelt oestradiol valerate in the UK) and norgestrel are forms of the main female sex hormones oestrogen and progesterone. Estradiol valerate is a naturally occuring form of oestrogen and norgestrel is a synthetic form of progesterone.

WomensÆ ovaries gradually produce less and less oestrogen in the period up to the menopause and oestrogen blood levels decline as a result. The declining levels of oestrogen can cause distressing symptoms such as irregular periods hot flushes night sweats mood swings and vaginal dryness or itching.

Oestrogen (in this case in the form of estradiol valerate) can be given as a supplement to replace the falling levels in the body and help reduce these distressing symptoms of the menopause. This is known as hormone replacement therapy (HRT). HRT is usually only required for short-term relief from menopausal symptoms and its use should be reviewed at least once a year with your doctor

A progestogen (in this case in the form of norgestrel) is needed as part of HRT for women who have not had a hysterectomy. This is because in women with an intact womb oestrogen stimulates the growth of the womb lining (endometrium) which can lead to endometrial cancer if the growth is unopposed. A progestogen is given to oppose oestrogen's effect on the womb lining and reduce the risk of endometrial cancer though it does not eliminate this risk entirely. This is known as combined HRT.

Cyclo-Progynova is a sequential form of combined HRT. This means that oestrogen is taken on a continuous basis and progesterone is added for a portion of each month. The white tablets taken in the first 11 days of each Cyclo-Progynova cycle contain only estradiol. The brown tablets taken in the next 10 days of each cycle contain both estradiol and norgestrel. After these 21 days you then have a seven day tablet-free break before the next cycle is started rather like the combined contraceptive pill. This type of HRT is more suitable for women who are still having irregular periods because it usually results in a monthly withdrawal bleed in the pill-free week.

HRT is also sometimes used to prevent osteoporosis in postmenopausal women. The declining level of oestrogen at menopause can affect the bones causing them to become thinner and more prone to breaking. Oestrogen supplements help prevent bone loss and fractures that may occur in women in the years after menopause.

However in December 2003 a review of the available evidence on the risks and benefits of HRT by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committee on Safety of Medicines (CSM) in the UK concluded that the risks of using HRT long-term to prevent osteoporosis in women aged over 50 years exceed the benefits. As a result this medicine should not be used as a first-line option for preventing postmenopausal osteoporosis in women over 50. However it may be used as a second-line option for women at high risk of fractures who cannot take other medicines that are licensed for preventing osteoporosis.

Women considered to be at high risk of developing fractures following the menopause include those who have had an early menopause those with a family history of osteoporosis those who have had recent prolonged corticosteroid therapy (eg prednisolone) those with a small thin frame and smokers.

You can read more about the risks and benefits of HRT and other medicines for preventing osteoporosis in the factsheets about menopause and osteoporosis linked below.

What is it used for?Hormone replacement therapy to relieve symptoms of the menopause.Second-line option for preventing osteoporosis in postmenopausal women who are at high risk of fractures and cannot take other medicines licensed for preventing osteoporosis.

Buy Cyclo Progynova Generic Estradiol valerate and other Prescription Drugs 5 products online at Medstore.

4950
Buy Online at Medstore - Click Here!

About Cyclo Progynova Generic Estradiol valerate:

Product Type: Prescription Drugs 5

Cyclo-Progynova ( Generic Estradiol valerate/Norgestrel )

Cyclo-Progynova (Generic Estradiol valerate/Norgestrel)

Generic Estradiol valerate/Norgestrel

2 mg/ 0 5mg 21 tabs Generic Estradiol valerate/Norgestrel Cyclo-Progynova

View more Prescription Drugs 5

Previous Product  Next Product

Online Prescriptions.
 
Industry News : Marquette General Health System joins Premier healthcare alliance. Marquette General Health System of Marquette, Mich., has joined the Premier healthcare alliance, consisting of more than 2,500 hospitals and 76,000 other healthcare sites, to improve care delivery. “We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier.” As a Premier owner, Marquette leverages a national purchasing network delivering industry-leading contract pricing. The not-for-profit health system formerly utilized MedAssets as its national purchasing organization. Marquette also collaborates and compares performance with other members of the alliance to improve care efficiency while safely reducing waste and costs using the nation's largest clinical, financial and operational database. "Premier's business model is unique in that it is completely owned by its members and thus accountable to and fully aligned with their goals," said Gary Muller, president & CEO at Marquette. "We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier." The health system participates in two Premier collaboratives for additional performance improvement opportunities. As a new member of Premier's ASCEND® (Accelerated Supply Chain Endeavor) program, Marquette aggregates, monitors and analyzes supply chain data to identify improvement opportunities. This includes simplified and consistent purchasing processes, appropriate clinical utilization and specially negotiated contracts. Members of ASCEND have saved $56 million over two years, without sacrificing the quality of care. To support its purchasing decisions, the health system uses Premier supply chain tools like SpendAdvisor® MySpend™, to easily examine spend data.
 
MACLAR Klacid 
Macrobid (Nitrofurantoin) 
Macrodantin (Nitrofurantoin Macrocystals) 
MADOPAR Prolopa 
Malirid Generic Primaquine 
Marvelon Desogestrel Ethinyl Oestradiol 
Maxalt (Rizatriptan) 
Maximune Invirase 
Maxolon Clopra 
Maxolon (Metoclopramide) 
MEBEX Vermox 
Medrol Deltastab 
MEFTAL Ponstel 
Melalite Forte Cream Aclaro 
Melanocyl Uvadex 
MELOSET MEL 
Memantine NAMENDA 
M Enalapril Generic Renitec 
Meprate Modus 
MESACOL Asacol 
Metaspray Nasonex 
Metformin Generic Glucophage 
Methotrexate 
Methycobal Generic Mecobalamin 
Metocard XL Toprol XR 
METOLAR Betaloc 
METOLAR H Selopres 
Metpamid Reglan